Repare Therapeutics Inc. Operating Income
Repare Therapeutics Inc. reported Operating Income of $1.13 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-11-14
- Repare Therapeutics Inc. operating income (loss) for the quarter ending 2025-09-30 was $1.13M.
- Repare Therapeutics Inc. operating income (loss) for the quarter ending 2025-06-30 was -$17.78M.
- Repare Therapeutics Inc. operating income (loss) for the quarter ending 2025-03-31 was -$31.19M, a 388.34% decline year-over-year.
- Repare Therapeutics Inc. operating income (loss) for the quarter ending 2024-12-31 was -$30.65M.
- Repare Therapeutics Inc. operating income (loss) for fiscal 2024 was -$93.52M.
- Repare Therapeutics Inc. operating income (loss) for fiscal 2023 was -$116.22M.
- Repare Therapeutics Inc. operating income (loss) for fiscal 2022 was -$19.80M.
- Repare Therapeutics Inc. operating income (loss) for fiscal 2021 was -$108.66M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-09-30 | $1.13M 10-Q · filed 2025-11-14 | -$16.65M derived: sum of 2 quarters · filed 2025-11-14 | -$47.84M 10-Q · filed 2025-11-14 | -$78.48M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | -$17.78M 10-Q · filed 2025-08-08 | -$48.97M 10-Q · filed 2025-08-08 | -$79.61M derived: sum of 3 quarters · filed 2025-08-08 | -$115.99M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | -$31.19M 10-Q · filed 2025-05-13 | -$61.84M derived: sum of 2 quarters · filed 2025-05-13 | -$98.21M derived: sum of 3 quarters · filed 2025-11-14 | -$135.53M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | -$30.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$67.02M derived: sum of 2 quarters · filed 2025-11-14 | -$104.34M derived: sum of 3 quarters · filed 2025-11-14 | -$93.52M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$36.37M 10-Q · filed 2025-11-14 | -$73.69M derived: sum of 2 quarters · filed 2025-11-14 | -$62.88M 10-Q · filed 2025-11-14 | -$93.74M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$37.32M 10-Q · filed 2025-08-08 | -$26.50M 10-Q · filed 2025-08-08 | -$57.37M derived: sum of 3 quarters · filed 2025-08-08 | -$95.79M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $10.82M 10-Q · filed 2025-05-13 | -$20.05M derived: sum of 2 quarters · filed 2025-05-13 | -$58.47M derived: sum of 3 quarters · filed 2025-05-13 | -$70.73M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$30.87M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$69.28M derived: sum of 2 quarters · filed 2025-03-03 | -$81.54M derived: sum of 3 quarters · filed 2025-03-03 | -$116.22M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$38.42M 10-Q · filed 2024-11-07 | -$50.68M derived: sum of 2 quarters · filed 2024-11-07 | -$85.36M 10-Q · filed 2024-11-07 | -$104.99M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$12.26M 10-Q · filed 2024-08-06 | -$46.94M 10-Q · filed 2024-08-06 | -$66.57M derived: sum of 3 quarters · filed 2024-08-06 | $6.83M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | -$34.68M 10-Q · filed 2024-05-07 | -$54.31M derived: sum of 2 quarters · filed 2024-05-07 | $19.09M derived: sum of 3 quarters · filed 2024-05-07 | -$19.65M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$19.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $53.77M derived: sum of 2 quarters · filed 2024-02-28 | $15.03M derived: sum of 3 quarters · filed 2024-02-28 | -$19.80M 10-K · filed 2024-02-28 |
| 2022-09-30 | $73.40M 10-Q · filed 2023-11-09 | $34.66M derived: sum of 2 quarters · filed 2023-11-09 | -$164.00K 10-Q · filed 2023-11-09 | -$28.90M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$38.73M 10-Q · filed 2023-08-09 | -$73.56M 10-Q · filed 2023-08-09 | -$102.30M derived: sum of 3 quarters · filed 2023-08-09 | -$133.98M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$34.83M 10-Q · filed 2023-05-09 | -$63.56M derived: sum of 2 quarters · filed 2023-05-09 | -$95.24M derived: sum of 3 quarters · filed 2023-05-09 | -$121.91M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$28.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$60.41M derived: sum of 2 quarters · filed 2023-02-28 | -$87.08M derived: sum of 3 quarters · filed 2023-02-28 | -$108.66M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$31.68M 10-Q · filed 2022-11-09 | -$58.35M derived: sum of 2 quarters · filed 2022-11-09 | -$79.93M 10-Q · filed 2022-11-09 | -$97.00M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$26.67M 10-Q · filed 2022-08-04 | -$48.25M 10-Q · filed 2022-08-04 | -$65.32M derived: sum of 3 quarters · filed 2022-08-04 | -$79.41M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | -$21.58M 10-Q · filed 2022-05-05 | -$38.66M derived: sum of 2 quarters · filed 2022-05-05 | -$52.74M derived: sum of 3 quarters · filed 2022-05-05 | -$65.07M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | -$17.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$31.16M derived: sum of 2 quarters · filed 2022-03-01 | -$43.49M derived: sum of 3 quarters · filed 2022-03-01 | -$54.30M 10-K · filed 2022-03-01 |
| 2020-09-30 | -$14.09M 10-Q · filed 2021-11-10 | -$26.41M derived: sum of 2 quarters · filed 2021-11-10 | -$37.23M 10-Q · filed 2021-11-10 | -$46.07M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | -$12.32M 10-Q · filed 2021-08-12 | -$23.14M 10-Q · filed 2021-08-12 | -$31.98M derived: sum of 3 quarters · filed 2022-03-01 | -$38.85M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | -$10.81M 10-Q · filed 2021-05-13 | -$19.66M derived: sum of 2 quarters · filed 2022-03-01 | -$26.53M derived: sum of 3 quarters · filed 2022-03-01 | -$32.41M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | -$8.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$15.71M derived: sum of 2 quarters · filed 2022-03-01 | -$21.60M derived: sum of 3 quarters · filed 2022-03-01 | -$26.38M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$6.87M 10-Q · filed 2020-11-12 | -$12.75M derived: sum of 2 quarters · filed 2020-11-12 | -$17.53M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$5.88M 10-Q · filed 2020-08-13 | -$10.66M 10-Q · filed 2020-08-13 |